ACADIA Pharmaceuticals Inc.

Q2 2026 13F Holders

Symbol
ACAD
CUSIP
004225108
Type
Equity
Class
COM
Num filings
369
Total reported value, excl. options
$4.40 B
Manager Report Date Value ($000) Shares Option Type